Looking to source high-purity KPV tripeptide for upcoming laboratory trials? PX1 Research provides USA-manufactured, fully analytical-grade KPV designed strictly for in vitro assays and animal models. Every lot is verified by independent third-party laboratories to ensure maximum purity, stability, and batch-to-batch consistency.
Looking to source high-purity KPV tripeptide for upcoming laboratory trials? PX1 Research provides USA-manufactured, fully analytical-grade KPV designed strictly for in vitro assays and animal models. Every lot is verified by independent third-party laboratories to ensure maximum purity, stability, and batch-to-batch consistency.
High-purity KPV (Lysine-Proline-Valine) tripeptide is available for laboratory research applications through PX1 Research. Derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH), research-grade KPV is synthesized in USA-based facilities under strict quality management protocols. Every production batch undergoes third-party RP-HPLC and mass spectrometry analysis to confirm purity exceeding 98%, accompanied by a lot-specific Certificate of Analysis for experimental reproducibility.
When investigative teams query for kpv til salgs, identifying a transparent supplier capable of providing rigorous chemical documentation is paramount. Substandard raw materials introduced into preclinical systems can yield confounding data, false-positive cell viability assays, or inconsistent receptor activation kinetics. PX1 Research eliminates these experimental variables by pairing ISO 17025 accredited analytical testing with documented endotoxin control, ensuring that your research team receives a dependable compound engineered exclusively for bench scientific evaluation.
KPV is a C-terminal tripeptide fragment consisting of the amino acid residue sequence Lysine-Proline-Valine. Structurally isolated as the active immunomodulatory motif of the larger peptide hormone alpha-MSH research, KPV retains significant biological signaling capacity while lacking the melanogenic properties associated with full-length melanocortin receptor agonists.
Because of its reduced molecular weight (344.41 g/mol), KPV exhibits unique physiological stability and diffusion characteristics compared to multi-residue polypeptides. In vitro studies demonstrate that the short-chain sequence resists rapid enzymatic cleavage by neutral endopeptidases, allowing investigators to study its cell-entry mechanisms and nuclear interaction profiles in sustained cellular cultures without premature degradation.
The primary mechanism documented in the scientific literature regarding KPV centers on its capacity to modulate nuclear factor kappa B (NF-κB) transcription factor activation. In cell culture models subjected to inflammatory stimuli such as lipopolysaccharide (LPS) or tumor necrosis factor-alpha (TNF-alpha), KPV demonstrates direct cellular internalization, interacting with intracellular targets to downregulate pro-inflammatory gene expression.
Preclinical assays indicate that KPV translocates into the nucleus and suppresses the translocation of the p65 subunit of NF-κB. By dampening this central signaling cascade, research models exhibit diminished transcription of downstream inflammatory mediators, including IL-6, IL-1beta, and inducible nitric oxide synthase (iNOS). Investigators utilizing our research library hub can review documented pathways detailing how this tripeptide selectively attenuates signal transduction without causing generalized cytotoxic immunosuppression.
A major area of academic investigation for KPV involves its role in preserving mucosal architecture and intestinal epithelial barrier function. In rodent models of dextran sulfate sodium (DSS)-induced colitis, researchers have observed that oral or systemic administration of KPV leads to reduced histological mucosal damage, diminished leukocyte infiltration, and lowered myeloperoxidase (MPO) activity within intestinal tissues.
In vitro monolayers using Caco-2 cell line models demonstrate that exposure to PX1 Research KPV preserves tight junction protein expression, specifically Zonula Occludens-1 (ZO-1) and occludin, under hyper-permeability challenge conditions. These structural observations suggest that KPV plays a fundamental role in stabilizing cellular junctions against cytokine-induced breakdown, providing a compelling foundation for ongoing gastroenterology research.
When evaluating agents for tissue barrier stabilization and inflammatory signaling assays, researchers often compare KPV against other established laboratory compounds. While KPV operates via intracellular nuclear factor modulation, compounds like BPC-157 exert their effects primarily through growth factor receptor signaling and nitric oxide pathway activation, promoting angiogenic repair pathways in connective tissues.
Similarly, peptide candidates such as Larazotide target tight junction assembly dynamics directly at the cell surface by inhibiting zonulin-mediated receptor transactivation. In contrast, antimicrobial host-defense peptides like LL-37 demonstrate broad-spectrum membrane-disrupting capabilities alongside immune cell recruitment. KPV remains distinct within this comparative landscape due to its ultrashort tripeptide sequence, high aqueous solubility, and targeted intracellular suppression of NF-κB transcription cascades.
To ensure reproducible data across multi-phase research studies, PX1 Research subjects every batch of KPV to stringent analytical characterization. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is conducted to verify chemical purity, ensuring that secondary synthesis side-products, truncated sequences, or residual protective groups are reduced below detectable limits.
Mass Spectrometry (MS) is simultaneously conducted to confirm the exact molecular mass and sequence integrity of the Lys-Pro-Val molecule. PX1 Research publishes comprehensive Certificates of Analysis (COAs) for every single lot. Laboratories seeking large-quantity procurement or continuous institutional supply can coordinate through our wholesale program to obtain lot-matched inventory supported by complete analytical documentation.
Bacterial endotoxin (lipopolysaccharide) contamination poses a severe threat to immunological and cellular assay accuracy. The presence of trace endotoxins in solid-phase peptide synthesis can artificially activate Toll-like Receptor 4 (TLR4), causing baseline cytokine release that completely invalidates inflammatory pathway research.
PX1 Research conducts quantitative Chromogenic Recombinant Factor C (rFC) or Limulus Amebocyte Lysate (LAL) assays on all KPV production runs, enforcing strict limits below 0.5 EU/mg. This process guarantees that observed cellular changes in your laboratory assays are attributable solely to KPV activity, rather than artifactual responses induced by residual endotoxin contaminants.
Research-grade KPV is supplied as a lyophilized (freeze-dried) powder to maximize chemical stability during transport and storage. For laboratory reconstitution, technicians should allow the vial to equilibrate to room temperature inside a laminar flow cabinet before opening to minimize atmospheric condensation within the container.
KPV exhibits excellent solubility in sterile laboratory-grade water, phosphate-buffered saline (PBS, pH 7.4), or standard cell culture media. Reconstitution should be performed using aseptic technique. Once dissolved, aliquoting the stock solution into single-use microcentrifuge tubes is strongly advised to avoid repetitive freeze-thaw cycles, which can induce physical peptide aggregation or gradual hydrolysis over time.
In its un-reconstituted, lyophilized form, KPV remains stable when stored at -20°C for short to medium durations, or at -80°C for extended research timelines. Desiccated storage containers should be utilized to prevent moisture absorption, which can catalyze slow peptide degradation even at sub-zero temperatures.
Reconstituted liquid solutions of KPV stored at 4°C should typically be utilized within 7 to 14 days to preserve peak experimental potency. For long-term studies requiring aqueous stock solutions, storage at -80°C is required. Researchers can browse our full catalog of anti-inflammatory peptides to review specific handling, storage, and stability profiles for related research reagents.
Acquiring KPV for scientific investigation requires a trusted vendor committed to chemical purity and regulatory compliance. PX1 Research synthesizes all compounds in state-of-the-art facilities located within the USA operating under GMP-compliant quality systems. Orders are fulfilled directly from our centralized distribution hubs in California and Arizona, ensuring rapid dispatch and minimal transit exposure.
By prioritizing rigorous analytical validation, transparent lot reporting, and dedicated researcher support, PX1 Research serves as the premier source for research facilities seeking top-tier KPV. Explore our dedicated catalog or contact our analytical support team to integrate verified research peptides into your experimental pipelines.
What is KPV tripeptide and how is it defined in research literature?
KPV is a tripeptide consisting of Lysine-Proline-Valine. In scientific literature, it is recognized as the active C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH) and is studied for its ability to modulate intracellular inflammatory cascades without engaging systemic melanocortin pathways.
How does KPV differ structurally from intact alpha-MSH?
Alpha-MSH is a 13-amino-acid peptide hormone, whereas KPV comprises only the final 3 amino acid residues (Lys-Pro-Val). KPV lacks the melanogenic amino acid sequence necessary to activate skin pigmentation pathways while retaining anti-inflammatory signal modulation.
What purity level is guaranteed for PX1 Research KPV?
PX1 Research guarantees a minimum purity of 98% for all KPV lots. Purity and identity are independently verified using RP-HPLC chromatography and mass spectrometry (MS).
What are the primary target pathways evaluated in KPV preclinical assays?
Preclinical studies primarily focus on KPV's inhibition of NF-κB nuclear translocation, down-regulation of pro-inflammatory cytokines (such as IL-6 and TNF-alpha), and stabilization of epithelial tight junction proteins (ZO-1 and occludin) in barrier tissue models.
Is KPV supplied by PX1 Research approved for human therapeutic use?
No. All products offered by PX1 Research, including KPV, are intended strictly for laboratory research, in vitro assays, and preclinical animal models. They are not for human consumption, clinical use, or therapeutic administration.
How should lyophilized KPV be stored upon arrival at the laboratory?
Lyophilized KPV powder should be stored at -20°C for short-term storage or at -80°C for long-term storage in a desiccated environment protected from light.
What solvent is recommended for reconstituting KPV for cell culture assays?
KPV readily dissolves in sterile laboratory-grade water, sterile 0.9% saline, or phosphate-buffered saline (PBS, pH 7.4). Solvents should be selected based on the specific buffer requirements of the downstream cellular assay.
How can research facilities verify the Certificate of Analysis for a KPV lot?
Every KPV order from PX1 Research includes batch identification that corresponds directly to downloadable, lot-specific COAs available on our website, detailing RP-HPLC purity charts, mass spectra, and endotoxin assay results.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.